Advances in predictive scoring system for intravenous immunoglobulin non-responsive Kawasaki disease
10.3760/cma.j.issn.1673-4408.2023.02.002
- VernacularTitle:静脉注射免疫球蛋白无反应型川崎病预测评分系统研究进展
- Author:
Yixu HUANG
1
;
Guanghuan PI
Author Information
1. 成都医学院附属妇女儿童医院小儿内科 610045
- Keywords:
Kawasaki disease;
IVIG non-response;
Scoring system
- From:
International Journal of Pediatrics
2023;50(2):77-80
- CountryChina
- Language:Chinese
-
Abstract:
Intravenous immunoglobulin(IVIG)is internationally recognized as the main treatment for Kawasaki disease(KD)in the acute phase, and its application can effectively reduce the incidence of coronary artery disease(CAL).However, in clinical practice, up to 26.8% of KD children do not respond to IVIG treatment, and their risk of CAL is higher and the degree of CAL is more severe.Early adjustment of treatment, such as early combined use of glucocorticoids, may play an important role in improving the prognosis and shortening the course of IVIG non-responsive KD.Therefore, early identification of IVIG non-response KD is of great significance to clinicians.In the past 20 years, domestic and foreign scholars have successively established predictive scoring system to predict the possibility of IVIG non-response in children with KD and optimize the early treatment.This article reviews the domestic and foreign research on the score system for predicting IVIG non-response in KD, in order to provide reference for clinical diagnosis and treatment.
